| Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma RB Ladju, D Pascut, MN Massi, C Tiribelli, CHC Sukowati Oncotarget 9 (2), 2951, 2018 | 47 | 2018 |
| Serum stem cell growth factor beta for the prediction of therapy response in hepatocellular carcinoma CHC Sukowati, R Patti, D Pascut, RB Ladju, P Tarchi, N Zanotta, M Comar, ... BioMed Research International 2018, 2018 | 26 | 2018 |
| Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma RB Ladju, ZS Ulhaq, GV Soraya World journal of gastroenterology 28 (2), 176, 2022 | 20 | 2022 |
| Expression ofmiRNA-29a-3pandIFN-γas biomarkers in active and latent pulmonary tuberculosis N Angria, MN Massi, A Bukhari, I Djaharuddin, O Jumadi, A Ahmad, ... Annals of Medicine and Surgery 83, 2022 | 11 | 2022 |
| Evaluation of the microscopic-observation drug-susceptibility assay drugs concentration for detection of multidrug-resistant tuberculosis TSS Anita, RB Ladju, N Massi Evaluation 1, 8582, 2014 | 6 | 2014 |
| Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma RB Ladju, D Pascut, MN Massi, C Tiribelli, CHC Sukowati Oncotarget 9 (16), 13101, 2018 | 1 | 2018 |
| Mycobacterium tuberculosis as a resilient foe in the mechanisms of colonisation, pathogenesis and host immune responses serves as a prerequisite for the development of … T Kansil, Z Amin, NA Yusof, ZA Zakaria, RA Mohd Mokhtar Malaysian Journal of Microbiology 19 (6), 2023 | | 2023 |
| The Importance of Death Receptor Pathway in Hepatocellular Carcinoma and It's Potential in the Development of Oligonucleotide Nanomedicine RBTE Ladju Università degli Studi di Trieste, 2019 | | 2019 |
| PO-091 Induction of anti-Fas regulates PUMA and MYC: P53-dependent apoptosis pathway in hepatocellular carcinoma cells RB Ladju, C Tiribelli, CH Sukowati ESMO Open 3, A56, 2018 | | 2018 |
| Research Article Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma CHC Sukowati, R Patti, D Pascut, RB Ladju, P Tarchi, N Zanotta, M Comar, ... | | 2018 |
| A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma C Sukowati, R Patti, D Pascut, RB Ladju, P Tarchi, N Zanotta, M Comar, ... Journal of Hepatology 68 (s), 685-685, 2018 | | 2018 |
| The role of gene polymorphisms of glutamate-cysteine ligase catalytic (GCLC) enzyme against antioxidants and oxidative stress status of Individual who had contacted infectious … MN Massi, S Rafiah, RB Ladju, GM Nurdin, A Zulkifli, A Yuniastuti Malaysian Journal of Microbiology, 322-326, 2016 | | 2016 |
| Evaluation of the Microscopic-Observation Drug-Susceptibility Assay Drugs Concentration for Detection of Multidrug-Resistant Tuberculosis SS Tangke, RB Ladju, N Massi International Journal of Bioengineering and Life Sciences 8 (5), 274-277, 2014 | | 2014 |
| Expression of miRNA-29a-3p and IFN-as biomarkers in active and latent pulmonary tuberculosis N Angria, MN Massi, A Bukhari, I Djaharuddin, O Jumadi, A Ahmad, ... | | |
| In vivo study In vitro study RB Ladju, C Tiribelli, CHC Sukowati | | |
